Testing effectiveness (Phase 2)Ended earlyNCT00048659
What this trial is testing
YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy
Who this might be right for
Hormone-Refractory Prostate CancerProstatic Neoplasms
Astellas Pharma Inc